atosiban 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
oxytocin antagonists 3008 90779-69-4

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • atosiban acetate
  • atosiban
  • Antocin II
  • antocin
  • tractocil
  • tractocile
Atosiban is a synthetic peptide which is a competitive antagonist of human oxytocin at receptor level. In human pre-term labour, atosiban at the recommended dosage antagonises uterine contractions and induces uterine quiescence.
  • Molecular weight: 994.19
  • Formula: C43H67N11O12S2
  • CLOGP: -0.02
  • LIPINSKI: 3
  • HAC: 23
  • HDO: 11
  • TPSA: 365.67
  • ALOGS: -4.28
  • ROTB: 18

Drug dosage:

DoseUnitRoute
165 mg P

ADMET properties:

None

Approvals:

FDA Adverse Event Reporting System (Female)

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Drug Use | Suggest Off label Use Form| |View source of the data|




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

External reference:

Pharmaceutical products:

None

atosiban